Jutta Deckert

Company: Iksuda Therapeutics

Job title: Vice President, Research & Development

Seminars:

Analyzing the Difference in Toxicity Profiles when Linker Stability is Altered in Order to Understand the Root Cause of Toxicity 9:30 am

Comparing the benefits of more stable linkers compared to more cleavable linkers Comprehending the mechanism of linker technology to understand premature/late release of the payload Investigating the relationship between linker type and the resulting toxicity Read more

day: Conference Day 2

Panel – Bench to Bedside & Back – Assessing the Benefits of a Reverse Translational Approach When Minimizing ADC Toxicities 12:00 pm

Viewing the ways toxicities present themselves clinically to consider what can be done preclinically to mitigate these effects Transferring from human studies to animal studies to obtain a deeper understanding of how different ADCs are distributed across healthy tissues Understanding potential biomarkers for predicting toxicities which present in humans and being able to connect this…Read more

day: Conference Day 2